RESUMO
BACKGROUND: Doxepin applied topically by itself or in combination with triamcinolone acetonide is a safe and effective treatment for atopic dermatitis. OBJECTIVE: We evaluated the pharmacokinetic profile of doxepin and desmethyldoxepin after topical application of doxepin hydrochloride 5% cream alone or in combination with 0.025% triamcinolone acetonide (doxepin/TAC). METHODS: Twenty-four subjects with atopic dermatitis received either doxepin or doxepin/TAC cream 4 times daily for 7 days in a randomized, double-blind, controlled trial. Serum samples were obtained and pharmacokinetic parameters estimated from the dose-normalized serum concentrations of doxepin and desmethyldoxepin. Efficacy and adverse experiences were determined by physician and subject evaluations. RESULTS: Pharmacokinetic parameters (K(e ), t(1/2 ) and AUC) calculated in 9 subjects (doxepin/TAC = 4 subjects, doxepin = 5 subjects) with detectable serum concentrations were similar for both groups. Pruritus relief and lessening of pruritus severity were significantly greater with doxepin/TAC than doxepin alone. CONCLUSION: Topically applied doxepin is safe and effective therapy for pruritus.
Assuntos
Antipruriginosos/farmacocinética , Dermatite Atópica/tratamento farmacológico , Doxepina/farmacocinética , Administração Tópica , Adulto , Anti-Inflamatórios/administração & dosagem , Anti-Inflamatórios/uso terapêutico , Antipruriginosos/administração & dosagem , Antipruriginosos/uso terapêutico , Método Duplo-Cego , Doxepina/administração & dosagem , Doxepina/análogos & derivados , Doxepina/uso terapêutico , Combinação de Medicamentos , Feminino , Humanos , Masculino , Pomadas , Triancinolona Acetonida/administração & dosagem , Triancinolona Acetonida/uso terapêuticoRESUMO
The increased number of patients with implantable cardiac devices presents a unique challenge to physicians performing office-based electrosurgical procedures. Electrosurgery can be performed safely if the electrosurgical techniques and potential risks from these devices are understood. We present an overview of the most common types of implantable cardiac devices, potential complications associated with them, and recommendations for preoperative evaluation, intraoperative monitoring, and postoperative follow-up.